|29 March 2016|
USA
Early stage industrial biotech companies are to be given a platform to promote themselves at the showcase event for the global industry.
The World Congress on industrial Biotechnology will feature these pioneers thanks to a partnership between organisers, the Biotechnology Innovation Organization (BIO) and America’s National Science Foundation (NSF).
“BIO and NSF have established a great public/private partnership, which first debuted at the 2013 BIO Investor Forum and will now be showcased at the 2016 BIO World Congress on Industrial Biotechnology,” said Brent Erickson, executive vice president for BIO’s Industrial & Environmental Section. “Through the SBIR grant program, qualified companies can move forward and bring innovative technologies to market. I hope everyone at the World Congress will take the time to stop by and learn about these exciting companies.”
“The BIO World Congress on Industrial Biotechnology is an excellent opportunity for these companies to showcase their cutting-edge technologies, form long-term partnerships and begin to raise funds in the private sector,” said Jesus Soriano, MD, PhD, MBA, a program director for NSF’s SBIR/STTR program. “NSF’s SBIR/STTR Program shows the government and private sectors working together toward the common goals of spurring job growth, building a bioeconomy, and reducing the costs and environmental footprint of manufacturing.”
BIO’s 13th Annual World Congress on Industrial Biotechnology will be held April 17-20, 2016 at the San Diego Convention Center in San Diego.
